Optimizing Post-Denosumab Treatment Approaches in Non-Metastatic Breast Cancer Patients Undergoing AI Therapy
Aromatase inhibitors (AIs) have solidified their position as essential agents in the adjuvant treatment landscape for hormone receptor–positive breast cancer, offering substantial reductions in disease...















